Sign up to get full access to all our latest Press Releases
Sign UpSign up to get full access to all our latest Press Releases
Sign UpJanuary 23, 2020
Rapid Dose Therapeutics and McMaster University Awarded NSERC Research and Development Grant to Develop Oral Dissolvable Film for Enhanced Drug DeliveryDecember 6, 2019
Rapid Dose Therapeutics Announces Shareholder Meeting Voting Results and New Chief Financial OfficerNovember 19, 2019
Health Canada Grants Micro-Processing Licence to Rapid DoseRAPID DOSE THERAPEUTICS INC.
Listing/Symbol: CSE: DOSE
Fiscal Year-End: February 28
Auditors: MNP
Legal Counsel:
OwenBird Law Corporations,
c/o Jeffrey Lightfoot
Share Structure
Shares Issued & Outstanding: 77,067,435
Warrants: 740,000
Options: 0
As of January 21, 2020
For inquiries
Ali Mahdavi
Managing Director
Spinnaker Capital Markets Inc.
Email: am@spinnakercmi.com
Phone: (416) 962-3300
